CV Scienceshas launched +PlusCBD Relief Softgels, which deliver seven times more CBDA and CBD than the +PlusCBD raw formula and feature Levagen+ PEA, a compound shown by clinical studies to be a potential alternative to ibuprofen. The company says that the product is intended to support a healthy inflammatory response and help manage occasional soreness.

www.cvsciences.com